Tesnatilimab
Tesnatilimab (JNJ-64304500) is a human IgG4 monoclonal antibody targeting NKG2D. Tesnatilimab can be studied in research for diseases such as Crohn’s disease (CD) and Inflammatory Bowel Disease (IBD). Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control.
Product Specifications
CAS Number
2242758-08-1
Product Name Alternative
JNJ-64304500; IPH-2301; NN-8555
UNSPSC
12352203
Target
C-type Lectin-like Receptors (CTLRs)
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tesnatilimab.html
Purity
99.80
Solubility
10 mM in DMSO
Smiles
[Tesnatilimab]
Molecular Weight
(143.9 kDa)
References & Citations
[1]Wei L, et al. The role of NKG2D and its ligands in autoimmune diseases: new targets for immunotherapy[J]. International Journal of Molecular Sciences, 2023, 24 (24) : 17545.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
